These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5380020)

  • 21. Management of pulmonary hypertension in the operating room.
    Subramaniam K; Yared JP
    Semin Cardiothorac Vasc Anesth; 2007 Jun; 11(2):119-36. PubMed ID: 17536116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary pulmonary hypertension. Treatment with prostacyclin I2 (epoprostenol)].
    Vicente R; Ramos F; Morales P
    Rev Esp Anestesiol Reanim; 1999; 46(6):274. PubMed ID: 10439652
    [No Abstract]   [Full Text] [Related]  

  • 23. [Good results in female arousal disorders and pulmonary hypertension. Sildenafil in another setting].
    MMW Fortschr Med; 2003 May; 145(20):61. PubMed ID: 12822236
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of the preparation CIBA 31 531-Ba on respiration and pulmonary circulation].
    Jedlicka K; Daum S; Nikodýmová L; Stiksa J
    Cas Lek Cesk; 1969 May; 108(21):629-33. PubMed ID: 5788079
    [No Abstract]   [Full Text] [Related]  

  • 25. Sildenafil for pulmonary arterial hypertension complicating respiratory disease.
    Aggarwal AN
    Indian J Chest Dis Allied Sci; 2008; 50(4):317-9. PubMed ID: 19035049
    [No Abstract]   [Full Text] [Related]  

  • 26. Sildenafil in the management of primary pulmonary hypertension.
    Singh B; Gupta R; Punj V; Ghose T; Sapra R; Grover DN; Kaul U
    Indian Heart J; 2002; 54(3):297-300. PubMed ID: 12216929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of inhalation of nebulized nitroglycerin on dogs with experimental pulmonary hypertension induced by U46619.
    Gong F; Shiraishi H; Momoi MY
    Chin Med J (Engl); 2000 May; 113(5):475-6. PubMed ID: 11776110
    [No Abstract]   [Full Text] [Related]  

  • 28. Pulmonary hypertension and right ventricular function: interdependence in pathophysiology and management.
    Afifi S; Shayan S; Al-Qamari A
    Int Anesthesiol Clin; 2009; 47(1):97-120. PubMed ID: 19131755
    [No Abstract]   [Full Text] [Related]  

  • 29. [Dynamics of electrocardiographic indices under the effect of certain hypotensive agents in patients with pulmonary hypertension].
    Zaslavskaia RM; Skvortsova TP; Katseva ED
    Sov Med; 1970 Mar; 33(3):137-8. PubMed ID: 5419165
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful treatment of severe portopulmonary hypertension in a patient with Child C cirrhosis by sildenafil.
    Callejas Rubio JL; Salmerón Escobar J; González-Calvín J; Ortego Centeno N
    Liver Transpl; 2006 Apr; 12(4):690-1. PubMed ID: 16555327
    [No Abstract]   [Full Text] [Related]  

  • 31. Revatio (sildenafil citrate) for the treatment of pulmonary arterial hypertension.
    Sahni J
    Conn Med; 2006; 70(6):381-3. PubMed ID: 16869470
    [No Abstract]   [Full Text] [Related]  

  • 32. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N; McAlpine L; Peacock AJ; Madhok R
    Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
    Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New indications for sildenafil in sight. Potency drug is potent in pulmonary hypertension].
    MMW Fortschr Med; 2004 Apr; 146(18):8. PubMed ID: 15366459
    [No Abstract]   [Full Text] [Related]  

  • 35. [Vasodilators, modern therapeutic approach in pulmonary arterial hypertension].
    Gherasim L; Bogdan M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(2):97-102. PubMed ID: 6127777
    [No Abstract]   [Full Text] [Related]  

  • 36. [No grounds for vasodilatory treatment in pulmonary hypertension].
    Petersen JR; Galløe AM; Graudal NA
    Ugeskr Laeger; 1994 Apr; 156(15):2219-21, 2224-6. PubMed ID: 8016946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Classic nitrate PETN (pentaerythritol tetranitrate). Initial data in pulmonary hypertension: no tolerance].
    MMW Fortschr Med; 2002 Nov; 144(45):50. PubMed ID: 12534063
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of Persistent Pulmonary Hypertension of the Newborn (PPHN) is in its infancy.
    Kissoon N
    J Crit Care; 2006 Jun; 21(2):223. PubMed ID: 16769472
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of pulmonary hypertension].
    Illaro Uranga A; Ibarra Barrueta O; Oribe Ibáñez M; Lertxundi Etxebarría U; Corcostegui Santiago B; Iglesias Lambarri A; Santos Ibáñez A
    Farm Hosp; 2004; 28(4):275-85. PubMed ID: 15369438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of primary pulmonary hypertension: one hundred years of search and disappointments].
    Belenkov IuN
    Ter Arkh; 1998; 70(9):16-8. PubMed ID: 9821218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.